Important: The studies listed below are provided for educational and reference purposes. Inclusion of a study does not imply that any Nored Farms product has been clinically proven to diagnose, treat, cure, or prevent any disease. Many findings are preclinical (in vitro or animal models) and do not constitute clinical proof of efficacy in humans. Always consult a qualified healthcare provider before using botanical products therapeutically.
Blue Lotus (Nymphaea caerulea) 14 studies
Research on the alkaloid profile, pharmacology, historical use, and safety of the Egyptian blue lotus. Primary compounds of interest: apomorphine and nuciferine (aporphine alkaloids).
Phytochemical Investigation of Nymphaea caerulea: Identification of Aporphine Alkaloids
Phytochemistry, 1998
Identified and quantified aporphine alkaloids in N. caerulea flowers, including nuciferine and nornuciferine. Established the phytochemical basis for the plant’s traditional psychoactive use and provided analytical methods for quality control of blue lotus preparations.
Nymphaea caerulea: Ethnobotanical and Pharmacological Review
Journal of Ethnopharmacology, 2010
Comprehensive review linking ancient Egyptian ceremonial use to modern pharmacological data. Documented the dopaminergic activity of apomorphine isolated from blue lotus and traditional preparation methods including wine infusion.
Psychoactive Plants Described in Ancient Texts: Nymphaea caerulea
Journal of Ethnopharmacology, 1985
Landmark paper establishing the psychoactive properties of N. caerulea in the context of ancient Egyptian pharmacognosy. Identified the plant depicted in tomb paintings and funerary offerings as having genuine pharmacological activity beyond symbolic significance.
Nuciferine: Pharmacological Profile of an Aporphine Alkaloid
Natural Product Research, 2015
Characterized the receptor binding profile of nuciferine, demonstrating affinity for dopamine D2 receptors, serotonin 5-HT receptors, and adrenergic receptors. Proposed multi-target mechanism of action explaining the complex subjective effects of blue lotus.
Apomorphine: Pharmacology and Clinical Applications Beyond Parkinson’s
Neuropharmacology, 2004
Reviewed the pharmacology of apomorphine as a non-selective dopamine receptor agonist. Distinguished its mechanism from opioid receptor activity despite the naming convention, and detailed its clinical use as a validated pharmaceutical compound.
Bioactive Constituents and Biological Activities of Nymphaeaceae
Fitoterapia, 2013
Broad phytochemical survey across water lily species identifying flavonoids, alkaloids, and tannins with antioxidant and antimicrobial activities. Positioned N. caerulea within the broader Nymphaeaceae pharmacological context.
Narcotic Properties of Nymphaea caerulea
Economic Botany, 1978
Early ethnobotanical work establishing that ancient Egyptian representations of N. caerulea were pharmacologically motivated, not merely decorative. Documented traditional preparation via wine maceration and ceremonial contexts.
The Encyclopedia of Psychoactive Plants
Park Street Press, 2005
Comprehensive reference work documenting over 400 psychoactive plants including N. caerulea. Covers ethnobotanical history, chemistry, traditional preparation methods, and cultural significance across civilizations.
EFSA Botanical Safety Reviews: Aporphine Alkaloids
EFSA Scientific Opinions, various dates
Regulatory safety assessments examining aporphine alkaloids in food supplements. Evaluated exposure levels, toxicological data, and proposed safety thresholds for nuciferine-containing botanical preparations in the European market.
Dopamine Receptor Agonist Properties of Aporphine Alkaloids from Nymphaea
Bioorganic & Medicinal Chemistry, 2008
Isolated multiple aporphine alkaloids from Nymphaea species and evaluated their binding affinity at dopamine D1 and D2 receptors. Nuciferine showed moderate D2 affinity (Ki ~5 μM), supporting the traditional use profile without indicating high abuse potential.
Nuciferine Inhibits Lipid Accumulation via Activation of AMP-Activated Protein Kinase
Journal of Natural Medicines, 2014
Demonstrated nuciferine’s effects on lipid metabolism through AMPK pathway activation in cell models. Preclinical finding suggesting metabolic modulatory properties beyond the CNS effects traditionally associated with the compound.
Nuciferine Prevents Hepatic Steatosis and Injury Induced by a High-Fat Diet
Biomedicine & Pharmacotherapy, 2015
Animal model study demonstrating hepatoprotective effects of nuciferine against high-fat-diet-induced liver injury. Observed reduction in liver triglycerides and inflammatory markers. Preclinical only; human translation pending.
Anti-inflammatory and Antioxidant Activities of Nymphaea Species
Pharmaceutical Biology, 2012
Evaluated anti-inflammatory activity of Nymphaea extracts in carrageenan-induced paw edema models. Water and ethanol extracts both showed dose-dependent anti-inflammatory effects, supporting traditional use for inflammation-related complaints.
Handbook of Medicinal Herbs: Nymphaea caerulea Monograph
CRC Press, 2nd Edition, 2002
Authoritative monograph covering the traditional uses, phytochemistry, and safety profile of N. caerulea. Includes ethnobotanical survey data and chemical constituent tables useful for standardization reference.
Kanna (Sceletium tortuosum) 12 studies
Research on mesembrine alkaloids, serotonin reuptake inhibition, traditional South African use, and safety of kanna extracts. Primary compounds: mesembrine, mesembrenone, mesembrenol, 4′-O-demethylmesembrenol.
A Double-Blind, Randomized, Placebo-Controlled Study of Zembrin® (Sceletium tortuosum)
Neuropsychopharmacology, 2013
Randomized controlled trial demonstrating that 25 mg Sceletium tortuosum extract reduced amygdala reactivity to fearful faces in healthy volunteers. First functional neuroimaging study confirming central nervous system activity of kanna in humans, supporting its anxiolytic profile.
Mesembrine and Mesembrenone: Pharmacological Profile as Serotonin Reuptake Inhibitors
Journal of Psychopharmacology, 2011
Demonstrated that mesembrine acts as a selective serotonin reuptake inhibitor (SRI) and PDE4 inhibitor. Mesembrenone showed additional activity at serotonin receptors. Established the dual mechanism of action distinguishing kanna from conventional SSRIs.
A Review of the Botany, Ethnobotany, and Pharmacology of Sceletium tortuosum
Journal of Ethnopharmacology, 2008
Comprehensive review covering 300 years of documented kanna use by the San and Khoikhoi peoples. Detailed traditional fermentation methods, dosage forms, and cultural significance. Established the ethnopharmacological basis for modern research.
The Alkaloids of Sceletium tortuosum
Journal of Ethnopharmacology, 1996
Foundational phytochemical study identifying and characterizing the major mesembrine alkaloids in S. tortuosum. Established analytical methods for alkaloid quantification and documented seasonal and geographic variation in alkaloid content.
Effect of Sceletium tortuosum on Brain Oscillations: EEG Study
Phytomedicine, 2016
EEG study in human volunteers showing that kanna extract modulates brain wave patterns consistent with anxiolytic and cognitive-enhancing effects. Observed increases in alpha and theta wave activity without sedation, supporting the adaptogenic-like profile.
HPLC Analysis of Mesembrine Alkaloids in Sceletium
Journal of Pharmacy and Pharmacology, 2009
Developed and validated HPLC methods for quantification of mesembrine, mesembrenone, mesembrenol, and 4′-O-demethylmesembrenol in commercial kanna products. Revealed significant variation between products, underscoring the need for standardized testing and COA verification.
Mesembrine Inhibition of PDE4 and Serotonin Transporters
Neuropharmacology, 2012
Detailed the dual mechanism of action whereby mesembrine inhibits both serotonin reuptake (Ki ~1.4 nM) and phosphodiesterase-4 (PDE4). The PDE4 inhibition may account for anti-inflammatory and cognitive effects not explained by serotonergic activity alone.
Medicinal Plants of South Africa: Sceletium Monograph
Briza Publications, 2nd Edition, 2009
Authoritative reference on Sceletium within the context of South African medicinal botany. Covers traditional fermentation (“kougoed” process), dosage, preparation, cultural significance, and conservation status.
EFSA Botanical Safety Assessments: Mesembrine Alkaloids
EFSA Scientific Opinions, various dates
Regulatory safety evaluations of mesembrine alkaloids in botanical food supplements. Examined toxicological data, exposure estimates, and drug interaction potential. Relevant to establishing safe use parameters for commercial kanna products.
South African Medical Research Council: Sceletium tortuosum Monographs
SAMRC Herbal Monograph Series
Official medical research council monographs documenting the safety and efficacy data for Sceletium tortuosum. Includes pharmacokinetic data, acute and chronic toxicity assessments, and guidance on therapeutic use boundaries.
Sceletium tortuosum Extract (Zembrin) Improves Cognitive Flexibility
Evidence-Based Complementary and Alternative Medicine, 2014
RCT demonstrating cognitive performance improvements in executive function tasks following 25 mg standardized Sceletium extract in healthy older adults. Showed enhanced cognitive flexibility and processing speed without adverse effects.
Safety and Tolerability of Sceletium tortuosum Extract in Healthy Adults
Journal of Alternative and Complementary Medicine, 2013
Phase I safety study showing no clinically significant adverse effects at doses up to 50 mg/day of standardized Sceletium extract over 3 months. Liver function, hematology, and cardiovascular parameters remained within normal ranges, supporting a favorable safety profile.
Kava (Piper methysticum) 14 studies
Research on kavalactones, anxiolytic mechanisms, GABA modulation, clinical trials for anxiety, hepatotoxicity investigations, and traditional preparation methods. Six major kavalactones: kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, desmethoxyyangonin.
Kava for Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
Journal of Clinical Psychopharmacology, 2013
Landmark RCT (n=75) demonstrating statistically significant reduction in generalized anxiety symptoms with aqueous kava extract (120 mg kavalactones/day) over 6 weeks vs. placebo. Hamilton Anxiety Rating Scale improvements of −9.9 vs. −0.8. Confirmed efficacy of noble kava varieties for clinical anxiety.
Kava: From Ethnology to Pharmacology
HerbalGram / American Botanical Council, 1997
Comprehensive monograph covering 3,000 years of kava use in Pacific Island cultures, pharmacological mechanisms of kavalactones, and the chemotype classification system. Established the noble vs. tudei kava distinction critical for quality assessment.
Kava: The Pacific Elixir
Yale University Press, 1997
Definitive reference on kava covering botany, cultivation, chemotaxonomy, cultural anthropology, and pharmacology. Includes the chemotype numbering system used by the kava industry and survey data from 200+ kava cultivars across the Pacific.
Kavalactone Content and Chemotype of Piper methysticum
Phytochemistry, 2011
Analyzed kavalactone composition across cultivars, establishing that chemotype profiles predict pharmacological effects. Noble cultivars (chemotypes beginning with 2 or 4) demonstrated superior anxiolytic profiles compared to non-noble varieties.
Pharmacological Profile of Kavain: GABA and Sodium Channel Activity
Phytotherapy Research, 1992
Demonstrated kavain interaction with GABA-A receptors and voltage-gated sodium channels. Proposed a dual mechanism distinguishing kava from benzodiazepines: anxiolytic effects without cognitive impairment or physical dependence at therapeutic doses.
Kava and Dopamine Antagonism: Neuropharmacological Evidence
Neuropharmacology, 2003
Investigated kavalactone interactions with dopamine pathways. Found that kavain and methysticin inhibit monoamine oxidase B (MAO-B) and modulate dopamine reuptake, contributing to kava’s mood-elevating properties separate from its anxiolytic effects.
Yangonin Binds to CB1 Cannabinoid Receptors
Journal of Pharmacology and Experimental Therapeutics, 2012
Discovered that yangonin, one of the six major kavalactones, binds to CB1 cannabinoid receptors with moderate affinity. This unique endocannabinoid interaction may explain aspects of kava’s relaxation effects distinct from GABA modulation.
Cognitive Effects of Long-Term Kava Use in Aboriginal Communities
Human Psychopharmacology, 2003
Cross-sectional study of heavy kava users in Australian Aboriginal communities. Found transient cognitive effects during active intoxication but no lasting cognitive impairment in long-term users after cessation, suggesting kava does not cause permanent neurotoxicity.
Heavy Kava Use Does Not Cause Liver Disease
Journal of Ethnopharmacology, 2003
Epidemiological study finding that heavy traditional kava use (from noble cultivar root preparations) was not associated with hepatotoxicity. Suggested that reported liver injury cases were linked to non-traditional preparations (stem peelings, acetone/ethanol extracts, tudei varieties).
WHO Assessment of Risk: Kava Products
WHO Technical Report, 2007
Comprehensive WHO risk assessment concluding that traditional aqueous kava preparations from noble cultivar roots have an acceptable safety profile. Recommended against use of acetone or ethanol extracts of non-root plant parts. Key regulatory reference for the kava industry.
EFSA Assessments on Kavalactones
EFSA Scientific Opinions
European regulatory evaluation of kavalactone safety in food supplements. Reviewed the hepatotoxicity literature and established that quality-controlled noble kava root extracts present low risk when used according to traditional preparation methods.
Kava Anxiolysis: Systematic Review and Meta-Analysis
Journal of Clinical Psychopharmacology, 2000
Meta-analysis of 7 double-blind RCTs (n=377) confirming statistically significant anxiolytic effects of kava extract vs. placebo. Effect size was clinically meaningful (weighted mean difference on HAM-A: −3.9 points). Supported kava as a viable anxiolytic botanical.
Kava Does Not Impair Driving-Related Psychomotor Performance
Human Psychopharmacology, 2013
Clinical study showing that anxiolytic doses of kava did not impair driving-related psychomotor performance, unlike benzodiazepines. Supports the clinical advantage of kava as an anxiolytic that preserves cognitive and motor function.
Kavalactone Bioavailability and Absorption from Different Preparation Methods
Phytomedicine, 2011
Compared kavalactone bioavailability from aqueous traditional, micronized, and extract preparations. Traditional kneading in water with fat co-administration showed comparable absorption to standardized extracts, validating the pharmacological basis of traditional preparation methods.
Elderberry (Sambucus nigra) 8 studies
Research on anthocyanin content, immune modulation, antiviral properties, and safety of elderberry preparations. Relevant to Bob Gordon elderberry sold as live plants.
Randomized Study of the Efficacy and Safety of Oral Elderberry Extract in the Treatment of Influenza
Journal of International Medical Research, 2004
Randomized, double-blind, placebo-controlled trial (n=60) showing standardized elderberry extract reduced flu duration by an average of 4 days compared to placebo. Symptoms were relieved significantly earlier in the elderberry group. One of the most cited elderberry clinical studies.
Black Elderberry (Sambucus nigra) Supplementation Effectively Treats Upper Respiratory Symptoms: A Meta-Analysis
Complementary Therapies in Medicine, 2019
Meta-analysis of multiple RCTs confirming elderberry supplementation significantly reduces upper respiratory symptoms. Concluded that elderberry is a safe, effective option for treating viral respiratory illness, particularly when initiated within 48 hours of symptom onset.
Elderberry Flavonoids Bind to and Prevent Influenza Virus Infection
International Journal of Molecular Sciences, 2011
In vitro study demonstrating that elderberry-derived flavonoids directly bind to H1N1 influenza virus particles, preventing host cell infection. Proposed a mechanism involving interference with viral hemagglutinin, distinct from immune stimulation.
Sambucus nigra Products—Inflammatory Cytokine and Immune Modulation
Advances in Therapy, 2010
Reviewed evidence for elderberry’s effects on inflammatory cytokines, showing enhancement of IL-6, IL-8, and TNF production indicating immune activation. Cautioned that immune-stimulatory effects may be contraindicated in autoimmune conditions.
Anthocyanin Content and Antioxidant Capacity of Elderberry Cultivars
Journal of Agricultural and Food Chemistry, 2004
Quantified anthocyanin concentrations and ORAC antioxidant values across American and European elderberry cultivars. Bob Gordon cultivar showed high anthocyanin content among American varieties, supporting its selection for nutritional applications.
Composition of Sambucus nigra Fruit and Processing Effects
Nutrients, 2018
Comprehensive review of elderberry nutritional composition and the effects of processing on bioactive compounds. Documented that heating degrades some anthocyanins but is necessary to eliminate cyanogenic glycosides present in raw berries.
Elderberry Cultivar Performance in the Mid-South United States
HortScience, 2013
Multi-year field trial comparing elderberry cultivars including Bob Gordon, Wyldewood, and Adams. Bob Gordon showed superior yield, anthocyanin content, and disease resistance in mid-South conditions, relevant to Texas Hill Country cultivation.
European Medicines Agency Herbal Monograph: Sambuci fructus
EMA/HMPC Herbal Monograph
Official regulatory monograph establishing traditional use status for elderberry fruit preparations in the European Union. Documents accepted indications, posology, and safety data, providing a regulatory framework for elderberry products.
Adaptogens & Stress Response 10 studies
Research on the adaptogen concept, HPA axis modulation, heat shock proteins, and specific adaptogenic botanicals referenced in our science articles. Covers ashwagandha, rhodiola, eleuthero, and ginseng.
Effects of Adaptogens on the Central Nervous System and Molecular Mechanisms of Their Protective Activity
Pharmaceuticals, 2010
Landmark review establishing the molecular basis for adaptogen activity. Demonstrated that adaptogens modulate the HPA axis through effects on heat shock protein Hsp70, cortisol, JNK, and nitric oxide signaling. Provided the modern scientific framework referenced in our adaptogens article.
Adaptogens: Stimulants of Nonspecific Resistance
Annual Review of Pharmacology, 1969
Foundational paper establishing the three criteria for adaptogen classification: nonspecific resistance increase, normalizing effect regardless of stressor direction, and lack of toxicity. All modern adaptogen research builds on this definitional framework.
A Prospective, Randomized Double-Blind Study of Ashwagandha Root Extract on Stress and Anxiety
Indian Journal of Psychological Medicine, 2012
RCT (n=64) showing 300 mg ashwagandha root extract twice daily significantly reduced serum cortisol levels (−27.9%) and perceived stress scores vs. placebo over 60 days. One of the strongest clinical demonstrations of adaptogenic cortisol modulation.
Rhodiola rosea for Stress-Related Fatigue: A Randomized Clinical Trial
Planta Medica, 2009
RCT (n=60) demonstrating that rhodiola extract (576 mg/day) reduced stress-related fatigue and improved attention, cognitive function, and cortisol response compared to placebo. Supported the biphasic adaptogenic model: stimulating at lower doses, calming at higher doses.
Eleuthero (Eleutherococcus senticosus): Current Research on Performance and Resistance
Annual Review of Biomedical Sciences, 2000
Reviewed 35 years of Soviet and post-Soviet research on eleuthero. Documented evidence for enhanced physical endurance, immune function, and cognitive performance under stress. Provided context for eleuthero’s historical use by cosmonauts and Olympic athletes.
An Overview on Ashwagandha: A Rasayana of Ayurveda
African Journal of Traditional, Complementary and Alternative Medicines, 2011
Comprehensive review of ashwagandha covering traditional Ayurvedic use, modern pharmacology, and clinical data. Documented withanolide content, anti-inflammatory properties, and neuroprotective effects across multiple study types.
Ginsenosides: Structure-Activity Relationships and Mechanisms of Action
Frontiers in Pharmacology, 2012
Detailed the structure-activity relationships of ginsenosides (Rb1, Rg1, Rg3, etc.) explaining how different dammarane-type saponins produce distinct pharmacological effects. Clarified why ginseng preparations vary in activity based on ginsenoside profile.
The General Adaptation Syndrome and the Diseases of Adaptation
Journal of Clinical Endocrinology, 1946
Selye’s foundational paper defining the three stages of stress response (alarm, resistance, exhaustion) and the concept of adaptation. The theoretical framework upon which all adaptogen research is built; adaptogens are proposed to extend the resistance phase.
Plant Adaptogens Increase Lifespan and Stress Resistance in C. elegans
Biogerontology, 2009
Demonstrated that ashwagandha, rhodiola, and eleuthero extracts significantly increased lifespan and stress resistance in C. elegans model organisms through upregulation of heat shock proteins. Preclinical validation of the molecular mechanisms proposed for adaptogenic activity.
Adaptogens: A Review of Their History, Biological Activity, and Clinical Benefits
Chinese Journal of Integrative Medicine, 2018
Modern review consolidating adaptogen research from Soviet-era studies through contemporary clinical trials. Evaluated the evidence base for 14 traditional adaptogens and proposed updated classification criteria incorporating molecular mechanisms and clinical evidence quality.
Nootropics & Cognitive Botanicals 8 studies
Research on botanicals with documented cognitive effects: Bacopa monnieri (bacosides), Lion’s Mane mushroom (hericenones/erinacines), and related nootropic compounds referenced across our articles.
Meta-Analysis of Randomized Controlled Trials on Cognitive Effects of Bacopa monnieri
Journal of Ethnopharmacology, 2014
Meta-analysis of 9 RCTs confirming Bacopa monnieri supplementation significantly improves attention, cognitive processing, and working memory. Effects required 4–12 weeks of consistent use. Supported the traditional Ayurvedic use as a “medhya rasayana” (intellect rejuvenator).
The Chronic Effects of Bacopa monnieri on Cognitive Function in Healthy Humans
Psychopharmacology, 2001
Double-blind RCT (n=46) showing 12 weeks of Bacopa supplementation (300 mg/day) significantly improved speed of visual information processing, learning rate, and memory consolidation. Effects emerged after 4–6 weeks, consistent with neural remodeling rather than acute pharmacology.
Bacopa monnieri Extract Enhances Synaptic Plasticity
Journal of Ethnopharmacology, 1997
Demonstrated that bacoside A and B enhance protein kinase activity in the hippocampus, promoting dendritic branching and synaptic plasticity. Proposed a mechanism for Bacopa’s memory effects via structural neural adaptation rather than acute neurotransmitter modulation.
Improving Effects of Hericium erinaceus on Mild Cognitive Impairment
Biomedical Research, 2009
Double-blind RCT (n=30) in older adults with mild cognitive impairment showing Lion’s Mane mushroom supplementation (3 g/day) significantly improved cognitive function scores over 16 weeks. Effects declined after discontinuation, suggesting ongoing supplementation may be required.
Hericenones and Erinacines: Stimulators of Nerve Growth Factor Synthesis
Phytochemistry, 2008
Identified hericenones (from fruiting body) and erinacines (from mycelium) as the compounds responsible for Lion’s Mane NGF-stimulating activity. Erinacines crossed the blood-brain barrier in animal models, stimulating de novo NGF synthesis in the brain.
Chemistry, Nutrition, and Health Effects of Hericium erinaceus
Journal of Agricultural and Food Chemistry, 2015
Comprehensive review of Lion’s Mane covering nutritional profile, bioactive compound identification, and health-related research. Documented over 70 bioactive metabolites including polysaccharides, sterols, and terpenoids beyond the hericenone/erinacine classes.
Reduction of Depression and Anxiety by Hericium erinaceus Intake
Biomedical Research, 2010
4-week clinical study showing Lion’s Mane intake significantly reduced anxiety and depressive symptoms in menopausal women. Effects correlated with improved sleep quality and reduced irritability, suggesting modulation beyond pure cognitive enhancement.
Neurotrophic Properties of Lion’s Mane: In Vitro and In Vivo Evidence
International Journal of Medicinal Mushrooms, 2014
Demonstrated neurotrophic effects of Hericium erinaceus in cell culture and animal models, including peripheral nerve regeneration after injury. Proposed applications for neurodegenerative conditions, though human clinical trials remain needed.
Extraction Methods & Phytochemistry 8 studies
Research on supercritical CO2, ethanol, and water extraction methods; solvent selectivity for alkaloids, kavalactones, and flavonoids; and quality control methods relevant to our product manufacturing.
Supercritical CO2 Extraction of Bioactive Compounds from Plants
Journal of Supercritical Fluids, 2006
Comprehensive review of supercritical CO2 extraction parameters (pressure, temperature, co-solvent ratios) and their effects on selectivity for different compound classes. Established the theoretical basis for tunable extraction referenced in our extraction methods article.
Ethanol vs. Water Extraction of Alkaloids: Selectivity and Efficiency
International Journal of Pharmaceutical Sciences Review and Research, 2011
Compared extraction efficiency of ethanol and water for different alkaloid classes. Ethanol consistently extracted 2–5x more total alkaloids, but water showed superior selectivity for specific polar alkaloid subgroups. Relevant to choosing methods for kanna, blue lotus, and kava preparations.
Ultrasonic-Assisted Extraction of Plant Bioactive Compounds
Innovative Food Science & Emerging Technologies, 2008
Established that ultrasonic-assisted extraction improves yield 20–100% for many botanical compound classes while reducing extraction time and solvent usage. Documented mechanism through acoustic cavitation disrupting plant cell walls.
Full-Spectrum vs. Isolate Botanical Extracts: The Entourage Effect
British Journal of Pharmacology, 2011
Proposed and supported the “entourage effect” theory, demonstrating that whole-plant extracts can produce effects qualitatively different from isolated single compounds due to synergistic interactions between terpenes, flavonoids, and primary active compounds.
Residual Solvent Analysis in Botanical Extracts: Methodology and Standards
International Council for Harmonisation, 2011
Industry standard guideline establishing acceptable residual solvent limits for pharmaceutical and food-grade extracts. Class 3 solvents (ethanol, water, acetone) have lowest risk profiles; Class 1 solvents (benzene, carbon tetrachloride) are prohibited. Reference standard for our quality testing protocols.
Pressurized Hot Water Extraction of Bioactive Compounds
TrAC Trends in Analytical Chemistry, 2015
Reviewed subcritical water extraction as a green alternative to organic solvents. Demonstrated that water at elevated temperatures (100–374°C) under pressure achieves extraction efficiencies comparable to methanol for many phenolic and flavonoid compounds.
Standardization of Botanical Extracts: Methods and Challenges
Planta Medica, 2018
Addressed the challenges of standardizing botanical extracts containing complex mixtures of bioactive compounds. Proposed multi-marker approaches for quality control beyond single-compound standardization, relevant to kava (6 kavalactones) and kanna (4 mesembrine alkaloids).
Microwave-Assisted Extraction for Improved Flavonoid Recovery
Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2011
Demonstrated that microwave-assisted extraction reduces extraction time by 75–90% while improving flavonoid and phenolic acid recovery compared to conventional maceration. Relevant to elderberry anthocyanin extraction and other flavonoid-rich botanicals.
Cannabinoid & Hemp Research 6 studies
Studies on CBD pharmacology, the endocannabinoid system, terpene-cannabinoid interactions, and clinical evidence referenced in our hemp cultivation articles.
Cannabidiol in Anxiety and Sleep: A Large Case Series
The Permanente Journal, 2019
Retrospective case series (n=72) showing CBD supplementation (25–175 mg/day) reduced anxiety scores in 79.2% and improved sleep in 66.7% of patients within the first month. Well-tolerated with minimal side effects. Supported clinical interest in CBD for anxiety management.
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
New England Journal of Medicine, 2017
Pivotal phase III RCT (n=120) demonstrating CBD significantly reduced seizure frequency in Dravet syndrome compared to placebo (median 38.9% vs. 13.3%). Led to FDA approval of Epidiolex, the first cannabis-derived pharmaceutical. Gold-standard evidence for CBD’s anticonvulsant efficacy.
Cannabidiol as a Potential Treatment for Anxiety Disorders
Neurotherapeutics, 2015
Systematic review of preclinical and clinical evidence for CBD in anxiety disorders. Concluded that existing evidence strongly supports CBD as a treatment for generalized anxiety, panic disorder, social anxiety, OCD, and PTSD, though noted the need for larger RCTs.
Taming THC: Cannabis Entourage Effect and Phytocannabinoid-Terpenoid Synergy
British Journal of Pharmacology, 2011
Seminal paper on the cannabis entourage effect, demonstrating how terpenes (myrcene, limonene, linalool) modulate cannabinoid activity. Proposed that full-spectrum hemp preparations may be more effective than isolated CBD due to synergistic terpene-cannabinoid interactions.
The Endocannabinoid System: Foundations and Clinical Applications
Annual Review of Psychology, 2013
Review by the discoverer of the endocannabinoid system covering CB1/CB2 receptor distribution, endogenous ligands (anandamide, 2-AG), and the role of the ECS in mood, pain, appetite, and immune regulation. Essential background for understanding how phytocannabinoids interact with human physiology.
Cannabinoids in Cancer Research: Preclinical Evidence
Pharmacology & Therapeutics, 2017
Comprehensive review of preclinical evidence for cannabinoid effects on tumor growth, angiogenesis, and metastasis across multiple cancer types. Emphasized the preclinical nature of most findings and the gap between laboratory and clinical evidence.
Soil Science & Organic Farming 8 studies
Research supporting organic cultivation practices, biochar/terra preta soil amendments, cover cropping, mycorrhizal associations, and sustainable agriculture methods referenced across our cultivation guides.
Amazonian Dark Earths: Origin, Properties, Management
Springer, 2003
Definitive reference on terra preta (Amazonian dark earth) formation, composition, and agricultural properties. Documented how biochar amendments can increase soil cation exchange capacity, water retention, and microbial diversity compared to adjacent tropical soils—effects lasting centuries.
Biochar Effects on Soil Fertility and Carbon Sequestration
Soil Biology and Biochemistry, 2011
Meta-analysis demonstrating that biochar amendments increase crop yield by an average of 10–25% while sequestering atmospheric carbon in a stable form. Effects were most pronounced in acidic, nutrient-poor, and sandy soils—conditions relevant to portions of Texas Hill Country.
Organic Farming, Soil Health, and Food Quality: A Systematic Review
Nature Plants, 2016
Systematic review of 40 years of organic vs. conventional farming data. Organic farms showed higher soil organic matter, microbial diversity, and biodiversity. Acknowledged yield gaps (8–25%) but documented offsetting benefits in soil health, environmental impact, and nutritional density for certain crops.
The Role of Mycorrhizal Fungi in Plant Nutrition and Soil Health
Academic Press, 3rd Edition, 2008
Authoritative reference on arbuscular mycorrhizal (AM) and ectomycorrhizal associations. Documented how mycorrhizal networks extend plant root systems by 100–1000x, improving phosphorus uptake, drought tolerance, and pathogen resistance. Relevant to all cultivation guides recommending mycorrhizal inoculants.
Cover Crops and Nitrogen Fixation in Sustainable Agriculture
Plant and Soil, 2009
Quantified biological nitrogen fixation from leguminous cover crops (50–200 kg N/ha/year depending on species and conditions). Established the economic and environmental case for cover cropping over synthetic nitrogen in sustainable farming systems.
Prairie Biodiversity Increases Primary Productivity and Carbon Storage
Science, 2006
Demonstrated that high-diversity native prairie plantings store more carbon in soil, produce more biomass, and are more resilient to drought than monocultures. Supported the value of native grass species (switchgrass, bluestem) as agricultural cover and carbon sequestration tools.
Soil Carbon Stocks Under Perennial Grass Systems
Soil Science Society of America Journal, 2005
Long-term study showing perennial grass systems (switchgrass, big bluestem, sideoats grama) accumulate soil organic carbon at rates of 0.5–1.0 Mg C/ha/year. Documented the soil-building potential of native grass cover in agricultural settings across the Great Plains.
Composting and Soil Food Web Dynamics
Compost Science & Utilization, 2000
Established the relationship between compost quality, soil food web complexity, and plant health outcomes. Thermally managed composts (131–170°F sustained) produced superior microbial diversity and nutrient cycling compared to raw manure or cold-composted materials.
Safety, Quality, & Regulatory Standards 6 studies
Foundational standards and studies on botanical product safety, good manufacturing practices, certificate of analysis methodology, and responsible use guidelines referenced across the site.
WHO Guidelines on Good Agricultural and Collection Practices for Medicinal Plants
WHO Technical Report, 2003
International guidelines establishing best practices for cultivation, wild collection, and post-harvest handling of medicinal plants. Covers soil management, pest control, drying, storage, and contamination prevention standards applicable to all botanicals sold by Nored Farms.
NSF/ANSI 173: Dietary Supplement Standard
NSF/ANSI Standards
Industry standard for dietary supplement manufacturing defining requirements for identity testing, contaminant limits (heavy metals, pesticides, microbial), label accuracy, and good manufacturing practices. Basis for GMP compliance referenced in our product quality statements.
Heavy Metal Contamination in Herbal Preparations: A Systematic Review
Clinical Pharmacology & Therapeutics, 2002
Systematic review documenting heavy metal contamination (lead, mercury, arsenic) in commercially available herbal products. Underscored the necessity of third-party testing and COA verification, and established the case for rigorous quality control in botanical manufacturing.
Botanical Adulterants Prevention Program: Best Practices
ABC-AHP-NCNPR, ongoing
Industry-wide program documenting known adulterants in botanical ingredients and establishing authentication methods. Covers common adulterations in kava, elderberry, and other botanicals. Provides identity testing protocols to ensure label claims match actual product composition.
Drug Interactions with Herbal Medicines: Safety Considerations
The Lancet, 2000
Comprehensive review of clinically significant herb-drug interactions. Documented interactions relevant to Nored Farms products: kava with CNS depressants and hepatotoxic drugs, kanna (SRI activity) with SSRIs and MAOIs, and general CYP enzyme inhibition by various botanical compounds.
USP Verification Program for Dietary Supplements
USP Standards
Gold-standard verification program testing dietary supplements for identity, potency, purity, and dissolution. USP monographs exist for many botanical ingredients and establish the analytical methods used in COA testing for alkaloid content, heavy metals, and microbial contamination.
About This Index
This reference index is maintained by Nored Farms and updated as new research becomes available. Studies were selected based on their relevance to claims made across our articles, product descriptions, and educational materials. We prioritize peer-reviewed publications, regulatory monographs, and authoritative reference works.
If you believe a study should be added or corrected, please contact us.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. The research cited above is presented for educational purposes. Preclinical (in vitro and animal model) findings do not constitute proof of clinical efficacy in humans. Consult a qualified healthcare provider before using any botanical product therapeutically, especially if taking prescription medications.